Free shipping for all order over $200 USD
$90.00
Adipotide is a category of pro-apoptotic peptides, born out of the revolutionary approach to cancer treatment. Apoptosis is a complex physiologic process which results in cell death, but what’s interesting about this group of peptides is that it only targets fat cells.
Adipotide, popularly known as FTPP, is an experimental weight loss treatment that causes programmed cell death of cells by eliminating their blood supply. This innovative compound has been studied in many animal research studies; therefore, it could be a game-changing approach to managing obesity and metabolic disorders.
The mechanism of action of Adipotide involves targeting the blood vessels that supply white adipose tissue. It binds receptors on the vascular structure of WAT, disrupting the vascular supply, leading to the starvation and eventual death of fat cells. This reduces fat mass and may improve metabolic health by decreasing insulin resistance and inflammation.
Adipotide was developed and entered phase one clinical trials in 2011, investigating its ability to induce fat cell apoptosis. Preclinical studies in rhesus monkeys have demonstrated that Adipotide specifically acts on the blood vessels feeding the white adipose tissue, causing death to fat cells. This leads to rapid weight loss, reduced body mass index, and increased sensitivity to insulin. The treated monkeys also showed decreased food intake, suggesting that it may affect appetite.
Although highly speculative, preliminary studies conducted on animals indicated that the mechanism through which Adipotide destroys blood vessels may help with cancer therapy. Prohibitin is the molecule this peptide largely targets in fat cells. It has also been linked with certain types of cancer.
Cancer cells need a large amount of blood to grow and metastasize. Focusing on prohibiting cancer cells could provide a way to treat cancer without damaging the surrounding healthy tissue.
Glucose tolerance means having higher-than-normal levels of blood sugar. Patients generally diagnose this condition with blood tests or by administering a glucose tolerance test, in which a patient consumes a certain amount of sugar, and then blood sugar levels are measured.
You can treat high glucose levels with diet and exercise, but these methods demand motivation and dedication. They also need a considerable amount of time to show the first results. Research involving Adipotide has revealed that this peptide produces weight-independent and rapid improvement in glucose tolerance. This means that Adipotide is able to reduce glucose tolerance regardless of the impact of weight.
In other words, losing fat content is important, not weight. These findings not only help us understand how this peptide works but also open new opportunities for developing innovative treatments for pre-diabetes and diabetes conditions and mechanisms that lead to the development of this illness. There are some doubts about whether this peptide directly causes fat loss or only minimizes food intake, which directly affects fat loss.
According to research done on animals, scientists concluded that Adipotide potentially causes fat loss. This hypothesis is supported by the fact that Adipotide can change cell density without affecting glucose tolerance and causing weight loss.
Reviews
There are no reviews yet.